Search Results
Nov 13, 2025, 07:00 ET U.S. GoldMining Welcomes Inclusion of Copper & Silver to U.S. Critical Minerals List, Highlights Whistler Gold-Copper Project in Alaska
Metallurgical recoveries are: 70% for Au, 83% for Cu, and 65% Ag for Ag grades below 10g/t. The Ag recovery is 0% for values above 10g/t for all deposits.
More news about: U.S. GoldMining Inc.
Nov 13, 2025, 05:00 ET IAE international engine partnership marks key milestones and charts future propulsion path
Japanese Aero Engines Corporation (JAEC), MTU Aero Engines AG (MTU) and Pratt & Whitney reaffirm commitment to engine partnership EAST
More news about: RTX
Nov 13, 2025, 02:01 ET Result of RetailBook Offer and Total Voting Rights
RetailBook is a proprietary technology platform owned and operated by Retail Book Limited (registered address at 10 Queen Street Place, London EC4R 1AG). Retail Book Limited ("RetailBook") is authorised and regulated in the United Kingdom by the Financial Conduct Authority (FRN 994238).
More news about: ACG METALS LIMITED
Nov 12, 2025, 20:06 ET EirGenix ha firmado el acuerdo de licencia comercial para su segundo biosimilar de HER2, EG1206A
2025 /PRNewswire/ -- EirGenix Inc. (TWSE: 6589) anunció el 12 de noviembre la firma de un segundo acuerdo global de licencia exclusiva con Sandoz AG (SIX:SDZ/OTCQX:SDZNY), líder internacional en biosimilares, para la comercialización de su biosimilar para el cáncer de mama, EG1206A (biosimilar de
More news about: EirGenix, Inc.
Nov 12, 2025, 20:05 ET EirGenix a signé un accord de licence commerciale pour son deuxième actif biosimilaire HER2, l'EG1206A
Inc.(TWSE: 6589) annoncé le 12 novembre la conclusion d'un deuxième accord mondial de licence exclusive avec le leader international des biosimilaires Sandoz AG (SIX:SDZ/OTCQX:SDZNY) pour la commercialisation de son biosimilaire pour le cancer du sein développé indépendamment, l'EG1206A (Biosimilaire de Perjeta®
More news about: EirGenix, Inc.
Nov 12, 2025, 11:01 ET Adaptive Cruise Control (ACC) System Market to Reach $12.7 billion, Globally, by 2034 at 8.5% CAGR: Allied Market Research
DENSO Corporation Robert Bosch GmbH Continental AG ZF Friedrichshafen AG VALEO SA Magna International Inc. Hyundai Mobis
More news about: Allied Market Research
Nov 12, 2025, 10:53 ET Head and Neck Cancer Drugs/Therapeutics Market Backed by Growing Adoption of Immunotherapy, Advancements in Targeted Treatment Approaches - Market Research Intellect
Merck & Co., Bristol-Myers Squibb, Eli Lilly and Company, AstraZeneca, Pfizer Inc., F. Hoffmann-La Roche Ltd., Novartis AG, Sanofi S.A., GlaxoSmithKline plc, and Bayer AG.
More news about: Market Research Intellect
Nov 12, 2025, 10:48 ET Telecommuting Market Fueled by Growing Hybrid Work Models, Enterprise Cloud Adoption, Virtual Collaboration Tools, and Rising Demand for Workplace Flexibility - Market Research Intellect
Market Size By Type (Wet Gel Electrodes, Dry Electrodes, Solid Gel Electrodes, Foam-Based Electrodes, Cloth-Based Electrodes, Silver/Silver Chloride (Ag/AgCl) Electrodes), By Application (Resting ECG, Stress Testing (Treadmill ECG), Holter Monitoring (24–48 hour ECG), Telemetry Monitoring, Diagnostic Electrophysiology
More news about: Market Research Intellect
Nov 12, 2025, 10:01 ET Water and Wastewater Treatment Equipment Market to Reach $90.02 Billion by 2030 - Grand View Research, Inc.
CORPORATION) Veolia Group Ecologix Environmental Systems, LLC Evonik Industries AG Parkson Corporation Lenntech B.V. Samco Technologies, Inc.
More news about: Grand View Research, Inc.
Nov 12, 2025, 10:01 ET Fragrance Diffuser Market to Reach $55.1 billion, Globally, by 2034 at 6.7% CAGR: Allied Market Research
International NEST Fragrances Corporation GreenAir Inc. Stadler Form AG Organic Aromas. The report analyses these key players in the global fragrance
More news about: Allied Market Research
Nov 12, 2025, 08:45 ET EirGenix Signed The Commercial Licensing Agreement for Its Second HER2 Biosimilar Asset EG1206A
EirGenix Inc.(TWSE: 6589) today announced that it has entered into a second global exclusive licensing agreement with international biosimilar leader Sandoz AG (SIX:SDZ/OTCQX:SDZNY) for the commercialization of its independently developed breast cancer biosimilar, EG1206A (Pertuzumab Biosimilar to Roche Perjeta®),
More news about: EirGenix, Inc.
Nov 12, 2025, 08:38 ET Leica Camera AG Launches New Project Fund: First LOBA Women Grant Open for Applicants in 2026
multimedia:https://www.prnewswire.com/news-releases/leica-camera-ag-launches-new-project-fund-first-loba-women-grant-open-for-applicants-in-2026-302612577.html
More news about: Leica Camera USA
Nov 12, 2025, 08:00 ET Luca Launches Three-Year, US$25 Million Exploration Program to Unlock Exceptional Gold Potential at Campo Morado and Tahuehueto
included: Campo Morado – Reforma: 37.2 metres of 5.9 g/t Au, 368 g/t Ag, 0.53% Cu, 5.54% Zn and 2.57% Pb , the first drillholes at this target in over 14 years. Tahuehueto
More news about: Luca Mining Corp.
Nov 12, 2025, 07:47 ET EirGenix Signed The Commercial Licensing Agreement for Its Second HER2 Biosimilar Asset EG1206A
EirGenix Inc.(TWSE: 6589) today announced that it has entered into a second global exclusive licensing agreement with international biosimilar leader Sandoz AG (SIX:SDZ/OTCQX:SDZNY) for the commercialization of its independently developed breast cancer biosimilar, EG1206A (Pertuzumab Biosimilar to Roche Perjeta®),
More news about: EirGenix, Inc.
Nov 12, 2025, 06:30 ET PMET Resources to Expand Land Position in James Bay Region
geological setting with strong potential for multiple commodities over several different deposit styles including orogenic gold (Au), porphyry (Au, Cu, Ag), and LCT pegmatite (Li, Cs, Ta, Ga, Rb). With the acquisition, the Company consolidates its land position in the region and now
More news about: PMET Resources Inc.
Nov 12, 2025, 06:00 ET VIZSLA SILVER DELIVERS POSITIVE FEASIBILITY STUDY FOR THE PANUCO PROJECT
Copala deposit with 7.90 Mt averaging 318 g/t Ag and 2.05 g/t Au Napoleon deposit with 4.91 Mt averaging 139 g/t Ag and 1.95 g/t Au
More news about: Vizsla Silver Corp.
Nov 12, 2025, 03:01 ET Accor shapes the future of hospitality with a bold vision, global mindset, and passion for sustainability
apartment hotel brand to the Chinese market, with 600 destinations across the country. In July, the Group also embarked on a strategic partnership with AG Group to franchise three new Emblems Collection hotels in Italy, adding some exceptional new hotels to the luxury brand's highly curated and growing
More news about: Accor
Nov 12, 2025, 03:01 ET Accor shapes the future of hospitality with a bold vision, global mindset, and passion for sustainability
apartment hotel brand to the Chinese market, with 600 destinations across the country. In July, the Group also embarked on a strategic partnership with AG Group to franchise three new Emblems Collection hotels in Italy, adding some exceptional new hotels to the luxury brand's highly curated and growing
More news about: Accor
Nov 12, 2025, 00:30 ET Sunsure Energy Signs 19.36 MW Round-the-Clock Wind-Solar Hybrid Agreement with Deepak Fertilisers, Pune
100% of their power use with round-the-clock clean energy (RE-RTC) from solar, wind, and battery storage solutions. Sunsure is backed by Partners Group AG with an equity commitment of $400 million towards its vision of building the largest industrial decarbonisation company in India and Southeast Asia.
More news about: Sunsure Energy
Nov 11, 2025, 18:41 ET Cohen Veterans Bioscience Selects Siemens Healthineers as Partner to expand the National Normative Neuroimaging Library (NNL)
/PRNewswire/ -- Cohen Veterans Bioscience, Inc. (CVB), a non-profit 501(c)(3) biomedical research and technology organization and Siemens Healthineers AG (SMMNY), a global leader in medical technology, today announced a landmark collaboration to enhance the national Normative Neuroimaging Library (NNL)
More news about: Cohen Veterans Bioscience
Nov 11, 2025, 17:31 ET Antibody-Mediated Rejection Market Set to Expand Significantly During the Forecast Period (2025-2034) Amid Advances in Diagnostics and Targeted Therapies | DelveInsight
therapy with broad applicability across various immune-mediated diseases, embodying a "pipeline-in-a-product" approach. Initially developed by MorphoSys AG (now MorphoSys GmbH, a Novartis company), Felzartamab has been exclusively licensed to Human Immunology Biosciences (HI-Bio) for development and commercialization
More news about: DelveInsight Business Research, LLP
Nov 11, 2025, 13:53 ET Lundbeck delivers 14% CER revenue growth, reflecting stronger momentum from Vyepti® and Rexulti® driven by additional investments
approval of its CHO manufacturing process and submission to the European Medicines Agency, supporting long-term supply scalability and cost efficiency. Lu AG09222 (anti-PACAP) continues to progress in phase IIb, with dose-response analyses guiding pivotal design, while a dual-active VIP-PACAP molecule has
More news about: H. Lundbeck A/S
Nov 11, 2025, 13:38 ET Lundbeck delivers 14% CER revenue growth, reflecting stronger momentum from Vyepti® and Rexulti® driven by additional investments
approval of its CHO manufacturing process and submission to the European Medicines Agency, supporting long-term supply scalability and cost efficiency. Lu AG09222 (anti-PACAP) continues to progress in phase IIb, with dose-response analyses guiding pivotal design, while a dual-active VIP-PACAP molecule has
More news about: H. Lundbeck A/S
Nov 11, 2025, 10:46 ET Gum Rosin Market to Reach $2.2 Billion, Globally, by 2034 at 4.7% CAGR: Allied Market Research
In June 2022, Harima Chemicals Group, Inc. completed the acquisition of commercial rights, assets, and other assets relating to Henkel AG & Co. KGaA's solder materials business. Henkel's Solder Material business is expected to strengthen Harima's potential to use its Tall Oil Rosin
More news about: Allied Market Research
Nov 11, 2025, 10:15 ET Machine Safety Market worth $7.45 billion in 2030 - Exclusive Report by MarketsandMarkets™
environmental concerns has propelled the installation of machine safety systems in regional industries. ABB (Switzerland), Siemens (Germany), and SICK AG (Germany) are the key players offering safety solutions and services to European manufacturing companies. Major companies operating
More news about: MarketsandMarkets